Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 81% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 90
- Reported
- 86
- Verified
- 77
- Gap
- +13
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Adopt with guardrails
- Why
- Genuinely FDA-approved and commercially deployed (1,000+ patients on adaptive therapy across a 40,000+ Percept installed base) with peer-reviewed long-term efficacy (98% continuation, 91% past one year), but real-world adoption is gated by clinician expertise and per-patient signal viability.
- Next
- Treat as a real, regulated, shipping product; cite FDA/CE approval and ADAPT-PD JAMA Neurology evidence, but flag the programming-expertise burden and the ~16% non-qualifying-signal rate in any maturity claim
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 5
- Tier 2
- 2
- Tier 3
- 0
- Supports
- 5
- Contradicts
- 2
- Context
- 0
- Latest observed
- 2025-10-09
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from mature to mature.
- 2026-09-22 Reading moved from mature to mature.